Access cutting-edge neuropathy treatment through this clinical trial at a research site in Cedar Rapids. Study-provided care at no cost to qualified participants.
Access neuropathy specialists in Cedar Rapids at no cost
This study follows strict safety protocols and ethical guidelines
All study-related neuropathy treatment provided free
This phase II trial tests the safety, side effects, and best dose of monosialotetrahexosylganglioside (GM1) and whether it works in reducing or preventing chemotherapy-induced peripheral neuropathy (CIPN) in patients with breast cancer that has spread from where it first started (primary site) to other places in the body (metastatic) who are receiving treatment with paclitaxel. Chemotherapy drugs, such as paclitaxel, work in different ways to stop the growth of cancer cells, either by killing th
Sponsor: Alliance for Clinical Trials in Oncology
Check if you qualify for this neuropathy clinical trial in Cedar Rapids, IA
If you're searching for neuropathy treatment options in Cedar Rapids, IA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Cedar Rapids research site is actively enrolling participants for this clinical trial. You'll receive care from experienced neuropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.